CCCC vs CCI · rev $35.6M vs P/E 40, rev $6.57B
C4 Therapeutics Inc (CCCC) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
CCCC currently screens at market cap $425.7M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the CCCC and CCI stock pages for the full models.
Not investment advice.